Vimarsana
Biggest News Aggregation in the World

Page 5 - Sciences Press News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sciences Press. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sciences Press Today - Breaking & Trending Today

Emmaus Life Sciences Announces Endari® To Be Added to the Florida Medicaid Preferred Drug List - Vimarsana News

Emmaus Life Sciences Announces Endari® To Be Added to the Florida Medicaid Preferred Drug List

/PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a leader in the treatment of sickle cell disease, announced today that the Florida Medicaid...

Emmaus Life Sciences Receives U.A.E. Marketing Authorization for Endari® - Vimarsana News

Emmaus Life Sciences Receives U.A.E. Marketing Authorization for Endari®

/PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA) a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today...

Emmaus Life Sciences' Real World Data on Endari® Accepted for E-Poster at the 62nd Annual Scientific Meeting of the British Society for Haematology - Vimarsana News

Emmaus Life Sciences' Real World Data on Endari® Accepted for E-Poster at the 62nd Annual Scientific Meeting of the British Society for Haematology

/PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease,...

Emmaus Life Sciences' Data on Endari® Accepted for Poster Presentation at the 63rd American Society of Hematology Annual Meeting & Exhibition - Vimarsana News

Emmaus Life Sciences' Data on Endari® Accepted for Poster Presentation at the 63rd American Society of Hematology Annual Meeting & Exhibition

/PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease,...

Emmaus Life Sciences Enters into Agreement with Asembia to Provide Expanded Patient Support Services - Vimarsana News

Emmaus Life Sciences Enters into Agreement with Asembia to Provide Expanded Patient Support Services

/PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease,...